- Open Access
Preface: From Science to Public Health: The Helicobacter pylori Case
Public Health Reviewsvolume 32, pages7–9 (2010)
The Nobel Prize for Medicine was awarded in 2005 to JR Warren and BJ Marshall for their identification of the bacteria Helicobacter pylori as the cause of peptic ulcer diseases, establishing another link between infection and chronic diseases. This dramatic scientific breakthrough led to curative treatments which reduced suffering from many acute and chronic conditions previously managed with a wide array of medical and surgical care, mostly with poor results. This discovery also had major implications for public health and healthcare systems with reduction in hospitalisation and surgery as well as in gastric cancer. Potential future benefits for global health will be expanded through control of infection with this organism which affects half of the world population. Hopefully, a vaccine will soon be found to augment individual care and sanitary methods of control of this common bacterial infection. Professor Robin Warren here recalls the process of this monumental discovery.
Normark S. Presentation speech of the Nobel Prize for Physiology or Medicine, 2005. On behalf of the Nobel Foundation, Karolinska Institute, December 10, 2005. http://nobelprize.org/nobel_prizes/medicine/laureates/2005/presentationspeech.html (Accessed 22 January, 2010).
Peek RM, Blaser MJ. Reviews: Helicobacter pylori and gastrointestinal cancer tract adenocarcinomas. Nature Rev. 2002;2:27–37.
National Cancer Institute. H. pylori and Cancer: Fact Sheet, October 17, 2006. (Accessed 22 January, 2010).
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22:283–97.
World Health Organization. Initiative for Vaccine Research: Helicobacter pylori http://www.who.int/vaccine_research/documents/Helicobacter_pylori/en/index.html (Accessed 22 January, 2010).